
### [DOID:0060100](http://purl.obolibrary.org/obo/DOID_0060100)
**Label:** musculoskeletal system cancer

**Subclasses:** [DOID:3246](http://purl.obolibrary.org/obo/DOID_3246) (embryonal rhabdomyosarcoma), [DOID:3369](http://purl.obolibrary.org/obo/DOID_3369) (Ewing sarcoma), [DOID:3347](http://purl.obolibrary.org/obo/DOID_3347) (osteosarcoma), [DOID:5485](http://purl.obolibrary.org/obo/DOID_5485) (synovial sarcoma), [DOID:2775](http://purl.obolibrary.org/obo/DOID_2775) (long bone adamantinoma), [DOID:4051](http://purl.obolibrary.org/obo/DOID_4051) (alveolar rhabdomyosarcoma), [DOID:6496](http://purl.obolibrary.org/obo/DOID_6496) (extraskeletal myxoid chondrosarcoma), [DOID:3371](http://purl.obolibrary.org/obo/DOID_3371) (chondrosarcoma), [DOID:5363](http://purl.obolibrary.org/obo/DOID_5363) (myxoid liposarcoma), [DOID:4239](http://purl.obolibrary.org/obo/DOID_4239) (alveolar soft part sarcoma), 

**Corr. equiv. classes:** [OMIM:268210](http://purl.obolibrary.org/obo/OMIM_268210), [OMIM:268220](http://purl.obolibrary.org/obo/OMIM_268220), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [OMIM:612237](http://purl.obolibrary.org/obo/OMIM_612237), [OMIM:606243](http://purl.obolibrary.org/obo/OMIM_606243), [Orphanet:99757](http://www.orpha.net/ORDO/Orphanet_99757), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [OMIM:215300](http://purl.obolibrary.org/obo/OMIM_215300), [OMIM:300813](http://purl.obolibrary.org/obo/OMIM_300813), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [OMIM:102660](http://purl.obolibrary.org/obo/OMIM_102660), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0100737](http://purl.obolibrary.org/obo/HP_0100737) (Abnormality of the hard palate))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0031105](http://purl.obolibrary.org/obo/HP_0031105) (Abnormal uterus morphology))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0030960](http://purl.obolibrary.org/obo/HP_0030960) (Abnormal pupillary morphology))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0030506](http://purl.obolibrary.org/obo/HP_0030506) (Yellow/white lesions of the retina))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011885](http://purl.obolibrary.org/obo/HP_0011885) (Hemorrhage of the eye))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation))) 68.37%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology))) 68.37%


